MKI67 and breast carcinoma: The International Ki67 in Breast Cancer Working Group recently proposed Ki67 ≤ 5% (low aggressive tumors) or ≥ 30% (high aggressive tumors) as reliable prognostic indicators for small T1-2 breast tumors (with or without metastatic spread to the axillary lymph nodes) [43].